Barts Health NHS Trust

Greater London E1 4DG

1 studies enrolling now · 2 studies all time

What they study most

Crohn Disease, Sjogrens Syndrome

Studies at this site

• A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• Nipocalimab in Moderate to Severe Sjogren's Disease — Running, not enrolling